Blue Water Life Science Advisors, LP Exact Sciences Corp Transaction History
Blue Water Life Science Advisors, LP
- $110 Million
- Q4 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 78,843 shares of EXAS stock, worth $3.71 Million. This represents 4.03% of its overall portfolio holdings.
Number of Shares
78,843
Previous 255,243
69.11%
Holding current value
$3.71 Million
Previous $17.4 Million
74.51%
% of portfolio
4.03%
Previous 15.28%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
152MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$826 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$801 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$568 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$294 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$271 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...